Algae cultivator Qualitas Health raises USD 10 million in funding round

By Nikita Chaurasia  Date: 2021-01-13

Algae cultivator Qualitas Health raises USD 10 million in funding round

In recent developments, privately held food and nutrition company Qualitas Health Inc. has reportedly secured USD 10 million in venture funds, as it looks to broaden the reach of its plant-based protein and omega-3 business. The company was appraised at USD 73 million during the closure of the first funding round.

The recently conducted funding round was led by renowned foodtech investor PeakBridge VC, along with other private investors including Minrav Holdings Ltd., Malta, and privately owned Mexican food service conglomerate, Arancia Group, cited sources with relevant information.

The funding round is aimed at accelerating customer acquisition as well as the commercialization of the firm’s unique plant-based protein. Moreover, Qualitas Health will utilize the funds to expand its existing clinical science channels and initiate product penetration in additional geographies.

CEO of Qualitas Health, Miguel Calatayud was reported saying that the recent investments will contribute to the company’s business expansion objective in 2021, while iwi parallelly progresses towards the industrial pilot stage of its product and conducts additional clinical studies. The company’s plant-based protein will be ready for commercialization and sale in 2022, he added.

For the record, Qualitas Health is a Texas-headquartered organization that focuses on developing pharmaceutical ingredients and high-value vegetarian food supplements. The company is best known for its algae brand, iwi, which is a direct-to-consumer manufacturer of high absorption polar lipid EPA omega 3.

Reportedly, iwi relies only on saltwater and solar energy to cleanly cultivate large amounts of Nannochrolopsis, a type of microalgae that consists of most of the essential amino acids, primarily omega 3.

With a goal of bringing sustainable and nutritious food solutions to cater to the growing population, Qualitas Health cultivates their algae in large cultivation pond systems in the deserts of Texas and New Mexico, as cited by credible sources.

Source credits -

https://www.prnewswire.com/news-releases/qualitas-healthiwi-raises-10m-in-first-close-of-new-investment-round-301205104.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...